TREM-1 blockade has previously been reported to be effective in vivo in murine collagen-induced arthritis, an experimental mouse model of RA, attenuating inflammation and improving the clinical course of the disease (58). This evidence concerns the gene TREM1 and rheumatoid arthritis.